Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral desensitization to antitubercular agents]

I Drira1, R Souissi, R Dakhlaoui

  • 1Service de Pneumologie, Pavillon B. Ariana, Tunis, Tunisie.

Revue De Pneumologie Clinique
|January 1, 1997
PubMed
Summary

Hypersensitivity reactions to major anti-tuberculosis drugs can be managed. Oral desensitization to Rifater was successfully performed, offering a new treatment option for patients with drug hypersensitivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isopropanol sensor based on sprayed In<sub>2</sub>S<sub>3</sub> thin film using linear discriminant analysis for real-time selectivity.

RSC advances·2024
Same author

Highly responsive and selective ozone sensor based on Ga doped ZnS-ZnO composite sprayed films.

RSC advances·2024
Same author

Annealing effect on the physical properties of TiO<sub>2</sub> thin films deposited by spray pyrolysis.

RSC advances·2023
Same author

Chemical VOC sensing mechanism of sol-gel ZnO pellets and linear discriminant analysis for instantaneous selectivity.

RSC advances·2023
Same author

Thickness effect on VOC sensing properties of sprayed In<sub>2</sub>S<sub>3</sub> films.

RSC advances·2022
Same author

Investigation of the effect of S/In molar ratio on physical properties of sprayed In<sub>2</sub>S<sub>3</sub> thin films.

RSC advances·2022

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Immunology

Background:

  • Tuberculosis remains a significant global health challenge, necessitating effective multi-drug regimens.
  • Hypersensitivity reactions to anti-tuberculosis drugs can complicate treatment, leading to drug discontinuation and suboptimal outcomes.
  • Rifater, a combination of rifampicin, isoniazid, and pyrazinamide, is a cornerstone of first-line tuberculosis treatment.

Observation:

  • A patient presented with a hypersensitivity reaction to major anti-tuberculosis drugs, specifically Rifater.
  • Standard treatment protocols were insufficient or contraindicated due to the adverse reaction.

Findings:

  • Successful oral desensitization to Rifater was achieved in the reported case.
  • A detailed protocol for oral desensitization was developed and implemented.

Related Experiment Videos

  • The developed protocol was compared with existing literature on drug desensitization.

    • Implications:

    • This case demonstrates the feasibility and success of oral desensitization for Rifater-induced hypersensitivity.
    • The presented protocol offers a valuable therapeutic strategy for managing anti-tuberculosis drug hypersensitivity.
    • Successful desensitization can enable patients to complete essential tuberculosis treatment regimens.